Renal cell carcinoma invading the inferior vena cava: use of a “temporary” vena cava filter to prevent tumor emboli during nephrectomy

Wellons, Eric D.; Rosenthal, David; Schoborg, Thomas W.; Shuler, Frederick W.; Levitt, Adam

doi:10.1016/j.urology.2003.10.010

Cited by 38 publications

(18 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[8][9] However, placing the filter is considered to increase the risk of thrombosis and inflammation. Generally, the permanent IVC filter may cause several complications, including extremity edema, infection and even organ's dysfunction.…”

Section: Discussionmentioning

confidence: 99%

Malignant epithelioid angiomyolipoma invading inferior vena cava: Using a temporary vena cava filter to prevent tumor emboli during nephrectomy.

Liu

2014

CUAJ

View full text Add to dashboard Cite

Cite as: Can Urol Assoc J 2014;8(7-8):e564-6. http://dx.doi.org/10.5489/cuaj.1814 Published online August 11, 2014. AbstractAngiomyolipoma (AML) is generally considered to be benign and malignant angiomyolipoma is rare. This paper presents an extremely rare case of epithelioid AML with tumour thrombus invading inferior vena cava (IVC). We present the case of a 36-year-old woman with epithelioid AML with tumour thrombus invading inferior vena cava who underwent radical nephrectomy and IVC thrombectomy. As an adjunctive procedure, a temporary IVC filter was placed in suprarenal position before operation. One week after surgery, the temporary IVC filter was retrieved by femoral approach. Three months postoperatively, a computed tomography scan and abdominal ultrasonogaphy showed no evidence of thrombus in IVC or renal vein and no sign of tumour recurrence. Epithelioid AML is extremely rare and can be malignant, with invasion of the IVC or renal vein. Implanting temporary filter can prevent fatal pulmonary complication and avoid potential the side effects of permanent filter.

show abstract

Section: Discussionmentioning

confidence: 99%

Malignant epithelioid angiomyolipoma invading inferior vena cava: Using a temporary vena cava filter to prevent tumor emboli during nephrectomy.

Liu

2014

CUAJ

View full text Add to dashboard Cite

show abstract

“…Wellons et al [29] in their study reported two cases of suprarenal IVC filter implantation in patients with renal cell carcinoma and IVC thrombosis. The placement of a temporary IVC filter in the suprarenal vena cava is innocuous, safe and simple.…”

Section: • Adrenal Glandmentioning

confidence: 98%

“…Pulmonary embolism (PE) or lethal pulmonary embolism and renal failure can be possible complications [29].…”

Section: • Adrenal Glandmentioning

confidence: 99%

See 1 more Smart Citation

Current role of interventions in metastatic kidney tumors: single center experience

et al. 2011

View full text Add to dashboard Cite

This study on the treatment of kidney tumor metastases aims to expose our experience in different interventional therapies for renal cell carcinomas metastasis in different organs, broaching their complications and comparing our results with the literature. In the last 5 years, after informed consent, 22 patients with metastatic kidney tumors were enrolled in this retrospective observational study. According to lesion sites, different interventional procedures may be performed: RFA for pancreas, lung, adrenal gland and liver lesions; TAE and RFA for bone lesions and IVC filter positioning for thrombosis of renal vein. There were mainly satisfactory results: complete necrosis of pancreas, lung and adrenal gland metastasis with a technical success rate of 100%; after TAE and RFA of bone lesions, an acceptable blood loss was registered during surgical intervention; no recurrences after liver metastasis ablation were observed in a period of 3 months; positioning of IVC filter was technically correct in 100% of patients; few complications, such as diffuse abdominal pain for pancreas, pneumothorax in the lung RCC metastasis and a post-RFA syndrome for the adrenal. There was a nodular recurrence along the ablation margin in one liver RCC metastasis. Inclusion criteria were relatively strict and only 22 patients were included in this study. The follow-up has been relatively short to date, so we are not certain of the long-term results, though these are comparable to those found in literature. It is possible to conclude that Interventional radiology plays an important role in RCC metastasis treatment, if we have few complications and improved outcomes.

show abstract

“…In recent years the use of temporary IVC filters has increased and advantages include no need for long-term anticoagulation therapy. Wellons et al [11] reported that placement of the OptEase temporary IVC filter at the proximal end of the tumor thrombus can prevent dislocation of the tumor thrombus during the surgery; however, the OptEase temporary filter is only applicable for level I tumor thrombi. In addition, removal of the filter requires the use of digital subtraction angiography (DSA) and special recovery equipment.…”

Section: Introductionmentioning

confidence: 99%

Tempofilter II for tumor emboli prevention during radical nephrectomy and inferior vena cava thrombus resection for renal cell carcinoma

Xiao

Bao

Jing

et al. 2009

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

Renal cell carcinoma invading the inferior vena cava: use of a “temporary” vena cava filter to prevent tumor emboli during nephrectomy

Cited by 38 publications

References 7 publications

Malignant epithelioid angiomyolipoma invading inferior vena cava: Using a temporary vena cava filter to prevent tumor emboli during nephrectomy.

Malignant epithelioid angiomyolipoma invading inferior vena cava: Using a temporary vena cava filter to prevent tumor emboli during nephrectomy.

Current role of interventions in metastatic kidney tumors: single center experience

Tempofilter II for tumor emboli prevention during radical nephrectomy and inferior vena cava thrombus resection for renal cell carcinoma

Contact Info

Product

Resources

About